Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Cash from Financing Activities (2020 - 2025)

Agilon Health's Cash from Financing Activities history spans 6 years, with the latest figure at -$17000.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 22.73% year-over-year to -$17000.0; the TTM value through Dec 2025 reached -$3.0 million, down 15.91%, while the annual FY2025 figure was -$3.0 million, 15.91% down from the prior year.
  • Cash from Financing Activities reached -$17000.0 in Q4 2025 per AGL's latest filing, up from -$236000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $1.1 billion in Q2 2021 to a low of -$202.0 million in Q2 2023.
  • Average Cash from Financing Activities over 5 years is $49.2 million, with a median of $727500.0 recorded in 2021.
  • Peak YoY movement for Cash from Financing Activities: surged 26688.13% in 2021, then tumbled 4788.72% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $10.4 million in 2021, then crashed by 89.15% to $1.1 million in 2022, then crashed by 174.78% to -$845000.0 in 2023, then skyrocketed by 97.4% to -$22000.0 in 2024, then increased by 22.73% to -$17000.0 in 2025.
  • Per Business Quant, the three most recent readings for AGL's Cash from Financing Activities are -$17000.0 (Q4 2025), -$236000.0 (Q3 2025), and -$2.6 million (Q2 2025).